Tomassini Luca, Ricchezze Giulia, Gambelunghe Cristiana, Lancia Massimo, Goracci Virginia, De Micco Francesco, Fedeli Piergiorgio, Cingolani Mariano, Scendoni Roberto
International School of Advanced Studies, University of Camerino, Camerino, Italy.
Department of Law, Institute of Legal Medicine, University of Macerata, Macerata, Italy.
Int J Legal Med. 2025 Apr 7. doi: 10.1007/s00414-025-03485-3.
The diagnosis of hyperthermia-related death presents a significant challenge in the field of forensic medicine due to the lack of pathognomonic signs and the complexity of the variables involved. This systematic review analyzes research on the role of immunohistochemistry (IHC) in postmortem diagnosis of hyperthermia, considering studies related to environmental hyperthermia, fire-related fatalities, and substance-induced hyperthermia. A total of 36 studies were included, selected according to PRISMA guidelines and critically evaluated using JBI tools. The results highlighted significant methodological heterogeneity, with differences in the tissues studied, the immunohistochemical markers used, and the analytical techniques employed. Some markers showed diagnostic potential in cases of fire exposure, but in deaths due to environmental or substance-induced hyperthermia, the markers examined were neither specific nor reliable. Common methodological weaknesses included small sample sizes, biases, and insufficient statistical analysis, which influenced the interpretation of the results. Considering these issues, IHC cannot be considered a valid diagnostic technique for hyperthermia-related deaths. Future studies with greater methodological rigor, validation of specific markers, and standardization of procedures are necessary.
由于缺乏特征性体征以及所涉及变量的复杂性,热射病相关死亡的诊断在法医学领域是一项重大挑战。本系统综述分析了免疫组织化学(IHC)在热射病死后诊断中的作用的研究,涵盖了与环境性高温、火灾相关死亡以及物质诱导性热射病相关的研究。共纳入36项研究,根据PRISMA指南进行选择,并使用JBI工具进行严格评估。结果凸显了显著的方法学异质性,在所研究的组织、所使用的免疫组化标志物以及所采用的分析技术方面存在差异。一些标志物在火灾暴露病例中显示出诊断潜力,但在环境或物质诱导性热射病导致的死亡中,所检测的标志物既不具有特异性也不可靠。常见的方法学弱点包括样本量小、偏差以及统计分析不足,这些都影响了结果的解释。考虑到这些问题,免疫组织化学不能被视为热射病相关死亡的有效诊断技术。未来需要开展方法学更严谨、特定标志物验证以及程序标准化的研究。